Zhenggang Ren

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 1K citations · Full text

Medicine, Oncology, Pharmacology +8

Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical Features, Treatment Modalities, and Prognosis

Xin Yin, Boheng Zhang, Shuang–Jian Qiu et al. · Annals of Surgical Oncology · 2012 · 228 citations

Medicine, Oncology, Pathology +16

Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling

Xin Yin, Boheng Zhang, Su-Su Zheng et al. · Journal of Hematology & Oncology · 2015 · 164 citations · Full text

Medicine, Molecular Biology, Oncology +17

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

Guo‐Ming Shi, Xiaoyong Huang, Dong Wu et al. · Signal Transduction and Targeted Therapy · 2023 · 148 citations · Full text

Medicine, Oncology, Pharmacology +16

Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma

Wenwei Zhu, Jiajian Guo, Lei Guo et al. · Clinical Cancer Research · 2013 · 141 citations · Full text

Medicine, Oncology, Pathology +16